| Literature DB >> 32529478 |
Regina Strakhova1, Octavia Cadassou1, Emeline Cros-Perrial1, Lars Petter Jordheim2.
Abstract
Cancer has the ability to escape the immune system using different molecular actors. Adenosine is known to be involved in mechanisms which control inflammatory reactions and prevent excessive immune response. This purine nucleoside can be translocated from the cell or produced in the extracellular space by 5'-ectonucleotidases. Once bound to its receptors on the surface of immune effector cells, adenosine activates various molecular pathways, which lead to functional inhibition of the cell or its death. Some tumors are infiltrated by the different cells of immune system but are able to use adenosine as an immunosuppressive molecule and thus inhibit immune anticancer response. This mechanism is well described on adaptive cells, but much less on innate cells. This review outlines major effects of adenosine on innate immune cells, its consequences on cancer progression, and possible ways to block the adenosine-dependent immunosuppressive effect.Entities:
Keywords: Adenosine; Cancer; Dendritic cells; Inflammation; Macrophages; Mast cells; Microenvironment; NK cells; Neutrophils
Year: 2020 PMID: 32529478 PMCID: PMC7524890 DOI: 10.1007/s11302-020-09701-6
Source DB: PubMed Journal: Purinergic Signal ISSN: 1573-9538 Impact factor: 3.765